A recent scientific study has raised questions about whether a common type of blood pressure medicine could be linked to a higher risk of developing glaucoma, a serious eye disease that can slowly steal vision without obvious warning signs.
Millions of people around the world take blood pressure medication every day to protect their heart and blood vessels. These medicines are often lifesavers, but new research suggests that at least one group of them might come with an unexpected side effect for the eyes.
The medicines in question are called calcium channel blockers, often shortened to CCBs. Doctors commonly prescribe them to help relax blood vessels and lower blood pressure. They are also used to treat heart rhythm problems and chest pain. For many people, CCBs are an important part of staying healthy and preventing strokes or heart attacks.
However, scientists at Moorfields Eye Hospital and University College London looked deeply into health data from more than 427,000 adults in the United Kingdom and found something concerning. Out of all those people, over 33,000 were taking calcium channel blockers at the time their health information was studied.
The researchers compared people who took these drugs with people who did not. They carefully considered other details about the participants, such as age, lifestyle habits like smoking or drinking, and other medical conditions like diabetes or heart disease.
Even after adjusting for all of these factors, the study found that people who took calcium channel blockers were more likely to have glaucoma than those who were not using these medications.
One of the most surprising findings was that the increased risk of glaucoma did not appear when people were using other types of blood pressure medicines. This made the scientists wonder if calcium channel blockers might have a unique effect on the eyes.
What made the situation even more worrying was that the higher risk was seen even in people who had normal eye pressure. Normally, glaucoma is linked to high pressure inside the eye. This pressure slowly damages the optic nerve, which sends visual information from the eye to the brain. Once this nerve is damaged, the vision loss cannot be reversed.
Because glaucoma often develops without obvious symptoms in the early stages, many people do not realize they have it until their vision has already been affected. They might slowly lose their side vision, making it harder to see cars, people, or obstacles.
Over time, central vision can also be affected. In the worst cases, glaucoma can lead to blindness. For this reason, it is sometimes called the “silent thief of sight.”
The researchers do not yet know for certain if calcium channel blockers directly cause glaucoma. It is possible that these medications affect blood flow to the eye or change how the eye’s tissues work in a way that increases risk over time.
More studies are needed to fully understand what is happening inside the eye. The scientists have called for further long-term research to explore how these medications might influence the optic nerve and eye structures.
These findings are important because calcium channel blockers are widely prescribed across the world. If there truly is a link to glaucoma, it could affect the long-term care of many patients.
However, experts warn that people should not stop taking their blood pressure medication on their own. High blood pressure is a serious condition that can lead to heart attacks, strokes, and kidney damage if left untreated. Anyone who is currently taking calcium channel blockers should speak with their doctor before making any changes.
Doctors may suggest more frequent eye exams for patients who take these medications, especially for older adults or those with a family history of glaucoma. Regular eye check-ups can help catch early signs of the disease before serious vision damage happens. Early treatment can slow or stop further vision loss, even though it cannot restore vision that is already gone.
It is also important to be open about possible limits of the research. Some of the scientists involved in the study have connections to pharmaceutical companies.
This does not automatically make the results wrong, but it is something readers should be aware of when thinking about the findings. Transparency like this helps people better understand the full context of scientific work.
The complete results of the study were published in the medical journal JAMA Ophthalmology. The study provides valuable information for patients, doctors, and researchers who care about protecting both heart health and vision.
If you care about high blood pressure, please read studies about unhealthy habits that may increase high blood pressure risk, and drinking green tea could help lower blood pressure.
For more information about high blood pressure, please see recent studies about what to eat or to avoid for high blood pressure, and 12 foods that lower blood pressure.
Copyright © 2025 Knowridge Science Report. All rights reserved.
